Louisiana 2024 Regular Session

Louisiana House Bill HB633

Introduced
3/1/24  
Introduced
3/1/24  
Refer
3/1/24  
Refer
3/1/24  

Caption

Provides relative to mandatory drug testing, screening, and assessment for drug and specialty court participation for certain offenders (OR NO IMPACT See Note)

Impact

The potential impact of HB 633 on state laws includes refining the processes surrounding pretrial drug testing and treatment assessment. It establishes procedures that require immediate drug testing and ongoing random testing for arrested individuals, allowing the courts to more effectively identify those in need of rehabilitation services. Additionally, the bill facilitates the automatic expungement of the criminal records of individuals who successfully complete a designated drug or specialty court program, thereby aiding in their reintegration into society and reducing future criminality.

Summary

House Bill 633 aims to enhance the eligibility and requirements for participation in drug and specialty court programs for offenders, particularly focusing on those with substance use disorders. The legislation proposes mandatory drug testing for individuals arrested on drug-related offenses or crimes of violence, implementing these tests within 24 hours of booking. Those who test positive will be subject to a clinical screening to assess their suitability for treatment programs designed for rehabilitation rather than punitive measures.

Sentiment

The sentiment surrounding HB 633 appears to lean towards support for rehabilitation over punishment, aligning with broader national trends that favor restorative justice practices. Lawmakers and advocacy groups are recognizing the benefits of addressing substance use disorders through treatment rather than incarceration. Nonetheless, there may be concerns regarding the initial financial implications related to funding the required testing and treatment programs, as stated in the provisions of the bill, which depend on legislative appropriations.

Contention

Notable points of contention may arise regarding the allocation of state resources for drug testing and treatment programs, as well as ensuring that confidentiality provisions adequately protect individuals' rights while seeking help. There might be discussions about the need for sufficient funding to administer these programs effectively, given the rising costs associated with drug treatment and ongoing monitoring. Furthermore, the balance between public safety and support for nonviolent offenders could become a focal point of debate among legislators.

Companion Bills

No companion bills found.

Previously Filed As

LA HB870

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

LA HB2742

Hospitals; urine drug screening to include testing for fentanyl.

LA SB118

Provides for substance use disorder screening of all misdemeanor DUI offenders. (8/1/26) (EN NO IMPACT See Note)

LA HB388

Vehicle Laws - Drunk and Drugged Driving - Points Assessments

LA SB174

Provides relative to certain pregnancy screenings. (gov sig) (EN INCREASE GF EX See Note)

LA SB243

Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

LA HB125

Provides relative to the supervised release of sex offenders (EN NO IMPACT See Note)

LA SCR12

Creates the Drug and Specialty Courts Commission.

LA LD96

An Act to Amend the Motor Vehicles and Traffic Law Governing Mandatory Driver's License Suspension for Refusing Testing for Drugs or a Combination of Drugs and Alcohol

LA SB169

Provides relative to biomarker testing. (gov sig) (EN NO IMPACT See Note)

Similar Bills

No similar bills found.